Back to news
11 November 2026·Product Update

CapsoCam Plus AI Highlights now available in Australia

Related product: CapsoCam Plus

Optimal Surgical is launching AI Highlights for the CapsoCam Plus small bowel capsule endoscope. On 11 November 2026, CapsoVision’s video capsule endoscopy system application software was included on the Australian Register of Therapeutic Goods (ARTG 533376). Optimal Surgical ANZ Pty Ltd is the sponsor and CapsoVision Inc is the manufacturer. The software is listed as a Class IIb medical device.

AI Highlights is an AI-assisted reading feature inside CapsoView. During the usual video processing workflow, the software analyses frames captured by the CapsoCam Plus capsule and compiles frames identified for physician review. Depending on how the service is configured, those studies can then be read in CapsoView or CapsoCloud.

The feature is designed to support review of small bowel capsule endoscopy studies by surfacing frames suspected of containing clinically relevant findings. It works alongside CapsoCam Plus’s 360° panoramic imaging, within the same CapsoView and CapsoCloud environment used to process studies, read cases, and share them securely with the care team.

AI Highlights is intended for trained healthcare professionals. It supports physician review and does not replace clinical judgement. Clinicians remain responsible for interpreting the study. Please refer to the Instructions for Use for indications, contraindications, warnings, precautions, and limitations.

CapsoCam Plus remains a wire-free capsule with onboard storage, cleared for at-home ingestion, with four lateral cameras that capture a full 360° view of the small bowel mucosa. Contact Optimal Surgical to arrange a discussion of CapsoCam Plus and AI Highlights for your service.

Source: Optimal Surgical. ARTG 533376, Therapeutic Goods Administration, 11 November 2026.